Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.96 USD | -18.48% | -19.55% | +34.87% |
May. 10 | Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says | MT |
May. 10 | Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.87% | 3.07B | |
-27.67% | 9.87B | |
-17.30% | 2.74B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 772M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Transcript : Iovance Biotherapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023